skip to main content

Contact us to get started

Hope begins here.

If you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.

If you’re an employee looking for your AccessHope benefit, call 800.423.3232 and select Option 1.

AccessHope Discusses How Data and Collaboration Can Transform Cancer ...

07/23/25 - The Pursuit of Health Podcast

Our chief medical officer, Yousuf Zafar, MD, MHS, joins Eric Fethke, MD, on The Pursuit of Health podcast for a powerful conversation on what truly drives better cancer care. Together, they explore how precision care delivery—not just precision medicine—can transform outcomes by considering the full picture of a patient's life, not just their diagnosis. Read more

AccessHope Discusses Bridging Cancer Care Expertise for Better ...

07/09/25 - HealthTech Remedy

Cancer care is evolving at an unprecedented pace, and it’s never been more critical to bridge the gap between innovation and access. On the latest episode of the HealthTech Remedy Podcast, AccessHope’s chief medical officer, Yousuf Zafar, MD, MHS, explores how emerging treatments, rising costs, and disparities in access are reshaping the cancer care landscape. Read more

Johns Hopkins Joins Cancer AI Alliance

03/20/25 - Johns Hopkins Medicine

Harnessing the power of artificial intelligence (AI) will enable new strategies for tackling cancer in a collaborative venture that brings together team science and vast data resources. As part of the new, national Cancer AI Alliance (CAIA), scientists from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the Johns Hopkins Whiting School of Engineering will develop projects centered on using AI to enable precision cancer care, building better approaches to detect, intercept and treat cancers, considering each patient’s unique history and treatment path. Read more

A Vision for Health Equity in Childhood Cancer

03/17/25 - Dana-Farber Cancer Institute

Dana-Farber researchers have uncovered an alarming reality: children from low-income households are more likely to experience cancer relapse and face lower survival rates compared to their more privileged peers, despite receiving treatment on highly standardized clinical trials at top academic centers. Read more

New AccessHope Research Reveals Remote Cancer Expertise Can Significantly Impact Treatment Plans for Socioeconomically Disadvantaged and Non-Urban Patients

Read the Press Release